Cross‐sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment

por Cutter, Gary, Xin, Haichang, Aban, Inmaculada, Burns, Ted M., Allman, Phillip H., Farzaneh‐Far, Ramin, Duda, Petra W., Kaminski, Henry J.
Publicado 2019

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events

por Hehir, Michael K., Conaway, Mark, Clark, Eric M., Aronzon, Denise B., Kolb, Noah, Kolb, Amanda, Ruzhansky, Katherine, Sadjadi, Reza, De Sousa, Eduardo A., Burns, Ted M.
Publicado 2022

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

por Muppidi, Srikanth, Utsugisawa, Kimiaki, Benatar, Michael, Murai, Hiroyuki, Barohn, Richard J., Illa, Isabel, Jacob, Saiju, Vissing, John, Burns, Ted M., Kissel, John T., Nowak, Richard J., Andersen, Henning, Casasnovas, Carlos, de Bleecker, Jan L., Vu, Tuan H., Mantegazza, Renato, O'Brien, Fanny L., Wang, Jing Jing, Fujita, Kenji P., Howard, James F.
Publicado 2019

Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis

por Placek, Katerina, Benatar, Michael, Wuu, Joanne, Rampersaud, Evadnie, Hennessy, Laura, Van Deerlin, Vivianna M, Grossman, Murray, Irwin, David J, Elman, Lauren, McCluskey, Leo, Quinn, Colin, Granit, Volkan, Statland, Jeffrey M, Burns, Ted M, Ravits, John, Swenson, Andrea, Katz, Jon, Pioro, Erik P, Jackson, Carlayne, Caress, James, So, Yuen, Maiser, Samuel, Walk, David, Lee, Edward B, Trojanowski, John Q, Cook, Philip, Gee, James, Sha, Jin, Naj, Adam C, Rademakers, Rosa, Chen, Wenan, Wu, Gang, Paul Taylor, J, McMillan, Corey T
Publicado 2020